Log in to save to my catalogue

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppr...

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_884126089

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells

About this item

Full title

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells

Publisher

Berlin/Heidelberg: Springer-Verlag

Journal title

Rheumatology international, 2008-11, Vol.29 (1), p.9-16

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer-Verlag

More information

Scope and Contents

Contents

Rheumatoid arthritis (RA) is a systemic autoimmune disease mediated by T cells. Collagen type II (CII) is one of the autoantigens associated with RA. CII263-272 is a predominant CII antigenic peptide that can induce T-cell activation upon binding to MHC and interaction with the appropriate T-cell receptor (TCR). Altered CII263-272 peptides with sub...

Alternative Titles

Full title

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_884126089

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_884126089

Other Identifiers

ISSN

0172-8172

E-ISSN

1437-160X

DOI

10.1007/s00296-008-0634-4

How to access this item